Abstract
Epsilon-poly-l-lysine (EPL) is an antimicrobial peptide with low mammalian toxicity; thus, it is commonly used as food preservative. Here, the capacity of EPL to improve the efficacy of the antibiotics ampicillin (AMP), gentamycin (GEN), tetracycline (TCN), and methicillin (MET) against four bacterial pathogens, namely Pseudomonas aeruginosa PAO1, Klebsiella pneumoniae CG43, MET-sensitive Staphylococcus aureus ATCC 25923 (MSSA), and MET-resistant S. aureus ATCC 33591 (MRSA), was investigated. Some antibiotic–EPL combinations, i.e., AMP–EPL, GEN–EPL, and TCN–EPL, were particularly active against the pathogens through synergy, partial synergy, or additive effects. Additionally, MET–EPL displayed a partial synergistic effect against MRSA. GEN–EPL had the most powerful antimicrobial effect against MSSA: it eradicated the bacterium within an hour. Conversely, AMP–EPL and MET–EPL were the least potent combinations against MRSA, and TCN–EPL was least potent against K. pneumoniae; for these combinations, bactericidal activities occurred >10 h after initial treatments. All antibiotic–EPL treatments showed inhibitory activities against P. aeruginosa biofilm formation and enhanced preformed biofilm disruption in vitro. Similarly, the inhibition of biofilm formation on a porcine skin model was observed. Moreover, no significant cytotoxicity was detected for any antibiotic–EPL treatment in tests using Balb/3t3 fibroblasts. Given the rise in antibiotic-resistant bacteria, combining antibiotics with EPL may enhance antibiotic effectiveness, as shown in this study, while helping to avoid antimicrobial resistance.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Tyers M, Wright GD. Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Nat Rev Microbiol. 2019;17:141–55.
Geitani R, Ayoub Moubareck C, Touqui L, Karam Sarkis D. Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa. BMC Microbiol. 2019;19:1–12.
Grassi L, Maisetta G, Esin S, Batoni G. Combination strategies to enhance the efficacy of antimicrobial peptides against bacterial biofilms. Front Microbiol. 2017;8:2409.
Shukla SC, Singh A, Pandey A, Mishra A. Review on production and medical applications of ɛ-polylysine. Biochem Eng J. 2012;65:78–81.
Yoshida T, Nagasawa T. ε-Poly-L-lysine: microbial production, biodegradation and application potential. Appl Microbiol Biotechnol. 2003;62:21–6.
Ning H-Q, Lin H, Wang J-X. Synergistic effects of endolysin Lysqdvp001 and ε-poly-lysine in controlling Vibrio parahaemolyticus and its biofilms. Int J Food Microbiol. 2021;343:109112.
Najjar MB, Kashtanov D, Chikindas M. ε‐Poly‐l‐lysine and nisin A act synergistically against Gram‐positive food‐borne pathogens Bacillus cereus and Listeria monocytogenes. Lett Appl Microbiol. 2007;45:13–8.
Zhou C, Li P, Qi X, Sharif AR, Poon YF, Cao Y et al. A photopolymerized antimicrobial hydrogel coating derived from epsilon-poly-l-lysine. Biomaterials. 2011;32:2704–12.
Hyldgaard M, Mygind T, Vad BS, Stenvang M, Otzen DE, Meyer RL. The antimicrobial mechanism of action of epsilon-poly-l-lysine. Appl Environ Microbiol. 2014;80:7758–70.
Zahi MR, El Hattab M, Liang H, Yuan Q. Enhancing the antimicrobial activity of d-limonene nanoemulsion with the inclusion of ε-polylysine. Food Chem. 2017;221:18–23.
Yoshida T, Nagasawa T.ε-Poly-L-lysine: microbial production, biodegradation and application potential.Appl Microbiol Biotechnol.2003;62:21–6.
Tan Z, Shi Y, Xing B, Hou Y, Cui J, Jia S. The antimicrobial effects and mechanism of ε-poly-lysine against Staphylococcus aureus. Bioresour Bioprocess. 2019;6:1–10.
Koebnik R, Locher KP, Van Gelder P. Structure and function of bacterial outer membrane proteins: barrels in a nutshell. Mol Microbiol. 2000;37:239–53.
Berditsch M, Jäger T, Strempel N, Schwartz T, Overhage J, Ulrich AS. Synergistic effect of membrane-active peptides polymyxin B and gramicidin S on multidrug-resistant strains and biofilms of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2015;59:5288–96.
Chang Y, McLandsborough L, McClements DJ. Cationic antimicrobial (ε-polylysine)–anionic polysaccharide (pectin) interactions: influence of polymer charge on physical stability and antimicrobial efficacy. J Agric Food Chem. 2012;60:1837–44.
Guzel Kaya G, Medaglia S, Candela-Noguera V, Tormo-Mas MÁ, Marcos MD, Aznar E et al. Antibacterial activity of linezolid against gram-negative bacteria: utilization of ε-poly-l-lysine capped silica xerogel as an activating carrier. Pharmaceutics. 2020;12:1126.
Shi C, Zhao X, Liu Z, Meng R, Chen X, Guo N. Antimicrobial, antioxidant, and antitumor activity of epsilon-poly-L-lysine and citral, alone or in combination. Food Nutr Res. 2016;60:31891.
Standards, N.C.f.C.L. and Barry AL. Methods for determining bactericidal activity of antimicrobial agents: approved guideline. National Committee for Clinical Laboratory Standards Wayne, PA; 19. 1999.
Garty BZ, Offer I, Livni E, Danon YL. Erythema multiforme and hypersensivity myocarditis caused by ampicillin. Ann Pharmacother. 1994;28:730–1.
Guin J, Phillips D. Erythroderma from systemic contact dermatitis: a complication of systemic gentamicin in a patient with contact allergy to neomycin. Cutis. 1989;43:564–7.
Bjellerup M, Ljunggren B. Photohemolytic potency of tetracyclines. J Investig Dermatol. 1985;84:262–4.
Yow MD, Taber LH, Barrett FF, Mintz AA, Blankinship GR, Clark GE et al. A ten-year assessment of methicillin-associated side effects. Pediatrics. 1976;58:329–34.
Wang R, Xu D, Liang L, Xu T, Liu W, Ouyang P et al. Enzymatically crosslinked epsilon-poly-L-lysine hydrogels with inherent antibacterial properties for wound infection prevention. RSC Adv. 2016;6:8620–7.
Guo Z, Sui J, Ma M, Hu J, Sun Y, Yang L et al. pH-Responsive charge switchable PEGylated ε-poly-l-lysine polymeric nanoparticles-assisted combination therapy for improving breast cancer treatment. J Controlled Release. 2020;326:350–64.
Palmer J, Flint S, Brooks J. Bacterial cell attachment, the beginning of a biofilm. J Ind Microbiol Biotechnol. 2007;34:577–88.
Davison WM, Pitts B, Stewart PS. Spatial and temporal patterns of biocide action against Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother. 2010;54:2920–7.
Martinez M, Gonçalves S, Felício MR, Maturana P, Santos NC, Semorile L et al. Synergistic and antibiofilm activity of the antimicrobial peptide P5 against carbapenem-resistant Pseudomonas aeruginosa. Biochimica Biophys Acta (BBA)—Biomembr. 2019;1861:1329–37.
Shi D, Mi G, Wang M, Webster TJ. In vitro and ex vivo systems at the forefront of infection modeling and drug discovery. Biomaterials. 2019;198:228–49.
Acknowledgements
This work is supported by the Ministry of Science and Technology (MOST) (Grant number: 109-2320-B-007-007-MY3), Taiwan.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Sundaran, S., Kok, LC. & Chang, HY. Combination effect of epsilon-poly-L-lysine and antibiotics against common bacterial pathogens. J Antibiot 75, 354–359 (2022). https://doi.org/10.1038/s41429-022-00523-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41429-022-00523-9